Nothing Special   »   [go: up one dir, main page]

FI20020360A0 - New use of biologically active product - Google Patents

New use of biologically active product

Info

Publication number
FI20020360A0
FI20020360A0 FI20020360A FI20020360A FI20020360A0 FI 20020360 A0 FI20020360 A0 FI 20020360A0 FI 20020360 A FI20020360 A FI 20020360A FI 20020360 A FI20020360 A FI 20020360A FI 20020360 A0 FI20020360 A0 FI 20020360A0
Authority
FI
Finland
Prior art keywords
biologically active
new use
active product
new
product
Prior art date
Application number
FI20020360A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI112031B (en
Original Assignee
Valio Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valio Oy filed Critical Valio Oy
Priority to FI20020360A priority Critical patent/FI112031B/en
Publication of FI20020360A0 publication Critical patent/FI20020360A0/en
Priority to AU2002352303A priority patent/AU2002352303A1/en
Priority to EP02788013A priority patent/EP1485119A1/en
Priority to JP2003569223A priority patent/JP4242293B2/en
Priority to RU2004128448/15A priority patent/RU2004128448A/en
Priority to PCT/FI2002/001051 priority patent/WO2003070267A1/en
Application granted granted Critical
Publication of FI112031B publication Critical patent/FI112031B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732Casein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/12Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI20020360A 2002-02-25 2002-02-25 New use of a biologically active product FI112031B (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product
AU2002352303A AU2002352303A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides
EP02788013A EP1485119A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides
JP2003569223A JP4242293B2 (en) 2002-02-25 2002-12-20 Composition for increasing bone strengthening and bone formation
RU2004128448/15A RU2004128448A (en) 2002-02-25 2002-12-20 INCREASING BIOAVAILABILITY OF MINERALS BY USING BIOLOGICALLY ACTIVE PEPTIDES
PCT/FI2002/001051 WO2003070267A1 (en) 2002-02-25 2002-12-20 Enhancing the availability of minerals by using biologically active peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20020360 2002-02-25
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product

Publications (2)

Publication Number Publication Date
FI20020360A0 true FI20020360A0 (en) 2002-02-25
FI112031B FI112031B (en) 2003-10-31

Family

ID=8563317

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20020360A FI112031B (en) 2002-02-25 2002-02-25 New use of a biologically active product

Country Status (6)

Country Link
EP (1) EP1485119A1 (en)
JP (1) JP4242293B2 (en)
AU (1) AU2002352303A1 (en)
FI (1) FI112031B (en)
RU (1) RU2004128448A (en)
WO (1) WO2003070267A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4723501B2 (en) * 2004-07-05 2011-07-13 カルピス株式会社 Method for producing peptide mixture, method for producing fermented milk containing antihypertensive peptide and method for producing antihypertensive peptide preparation
ES2384096T3 (en) * 2006-02-20 2012-06-29 Compagnie Gervais Danone Strains of Lactobacillus helveticus that do not ferment lactose
CA2652388A1 (en) * 2006-05-15 2007-11-22 Valio Ltd New use of therapeutically useful peptides
FI122531B (en) * 2009-09-30 2012-03-15 Valio Oy Cheese and process for making them
JP5888701B2 (en) * 2010-11-09 2016-03-22 アサヒグループホールディングス株式会社 Lactobacillus helveticus having high proteolytic activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ183858A (en) * 1976-12-17 1979-10-25 Ashmead Hh Polyvalent metal proteinates as food additives
HUT52962A (en) * 1988-03-04 1990-09-28 Sandoz Ag Process for production of medical compositions eliminating bone-absorption and promoting forming of bones
JP3488722B2 (en) * 1992-03-04 2004-01-19 カルピス株式会社 Calcium absorption promoting activator and method for producing the same
JP2782142B2 (en) 1992-07-23 1998-07-30 カルピス株式会社 Angiotensin converting enzyme inhibitor and method for producing the same
US6214800B1 (en) * 1995-10-25 2001-04-10 Senju Pharmaceutical Co., Ltd. Angiogenesis inhibitor
KR100221124B1 (en) * 1996-09-23 1999-10-01 한상기 Novel casein and preparing method thereof
JP3028411B2 (en) 1997-09-26 2000-04-04 カルピス株式会社 Lactobacillus helveticus lactic acid bacteria with high tripeptide productivity
FI113741B (en) * 1999-11-01 2004-06-15 Valio Oy Process for the preparation of a product containing peptides with antihypertensive effect
WO2001068115A1 (en) * 2000-03-13 2001-09-20 Monsanto Technology Llc Process for producing peptide sequences possessing anti-hypertension activity

Also Published As

Publication number Publication date
JP2005517424A (en) 2005-06-16
JP4242293B2 (en) 2009-03-25
EP1485119A1 (en) 2004-12-15
FI112031B (en) 2003-10-31
RU2004128448A (en) 2005-04-20
AU2002352303A1 (en) 2003-09-09
WO2003070267A1 (en) 2003-08-28

Similar Documents

Publication Publication Date Title
DE60324099D1 (en) DRUG-CONTAINING TAMPON
CY2015015I1 (en) PRODUCTION OF THIACOMYCIN
DE60312780D1 (en) disposable diaper
ATE370714T1 (en) SHAPED TAMPON
IS7571A (en) New physiologically active substances
DE60304102D1 (en) Skin cleansing composition
IS7714A (en) Pharmaceutical formulations of modafinil
NO20044916L (en) Preparations of sulfinylacetamide
DK1572229T3 (en) Stable therapeutic fibrinogen
ATE389742T1 (en) TISSUE TREATMENT PRODUCTS
IS2707B (en) New pharmaceutical formulations of modafinil
NO20043576L (en) Pharmaceutical formulation comprising melatonin
NO20050689L (en) Therapeutic use
FI20020360A0 (en) New use of biologically active product
DE60230292D1 (en) ACTIVE OXYGEN-PRODUCING MATERIAL
ES1052302Y (en) SUPPORT OF MEDICAL SUPPLIES.
EE200300434A (en) Use of pharmaceutically active compounds
IS7902A (en) Anti-skincare composition for skin care
NO20022747L (en) treatment chair
FI20021570A0 (en) Improved structure of coated surgical stent
PT1467737E (en) PHARMACEUTICAL COMPOSITION ORODISPERSIVEL OF PYRIBEDIL
DE60326437D1 (en) THERAPEUTIC USE OF SAPOGENINES
SE0201783D0 (en) Medical use
DOP2002000452A (en) PCT 2002
UA6408S (en) SET OF COOKIES "TURNAMENT"

Legal Events

Date Code Title Description
MM Patent lapsed